Myomo, Inc. (MYO)Healthcare | Medical Devices | Burlington, United States | NYSE American
1.10 USD
|
Hot Take ↕ | July 11, 2026, 3:28 a.m. EDT
The investment case here is defined by a stark disconnect between the company's deteriorating fundamentals and the market's desperate hope for a turnaround. Fundamentally, Myomo is in distress: it is burning significant cash, generating negative operating cash flow, and has posted a massive 99% cumulative decline over the last eight years. The balance sheet is fragile with debt exceeding cash reserves, and the return on equity is deeply negative. While revenue growth is technically positive at 2.9%, it is insufficient to offset the operational bleed, making this a classic value trap where the low price reflects real business decay rather than a bargain opportunity. However, the short-term outlook is driven entirely by speculative positioning rather than financial health. With zero put buying and heavy call open interest at strikes significantly above the current price, retail investors are positioning for a binary event—a product approval, a partnership, or a strategic acquisition—that could instantly re-rate the stock. This options flow creates a 'gamma squeeze' environment where any positive news could trigger explosive upside, but the absence of downside hedging also means there is no safety net if the catalyst fails to materialize. For a long-term investor, the multi-year decline and cash burn make holding unattractive; for a trader, the setup offers high-risk, high-reward potential dependent on a specific catalyst occurring soon. |
| Model | MAE |
|---|---|
| AutoTheta ✓ | 0.228252 |
| AutoETS | 0.247256 |
| MSTL | 0.247701 |
| AutoARIMA | 0.248771 |
Forecast horizon: 45 days | Selected: AutoTheta
| Forecast Reliability | |
|---|---|
| Score | 28% |
| H-stat | 48.73 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.331 |
| Excess Kurtosis | -0.85 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 210.649 |
| Revenue per Share | 1.069 |
| Market Cap | 42,502,520 |
| Forward P/E | -4.34 |
| Beta | 1.46 |
| Profit Margins | -36.69% |
| Website | https://myomo.com |
As of July 11, 2026, 3:28 a.m. EDT: Speculators are overwhelmingly bullish on the near term, evidenced by zero put volume and open interest across all expirations. Call activity is concentrated in out-of-the-money strikes (2.0 and 5.0), suggesting a bet on a sharp rebound or gap-up event. Implied volatility is extremely low (under 2%), indicating the market expects a flat or non-volatile path until the catalyst arrives, while the lack of downside protection suggests traders believe the floor is firm.
| Attribute | Value |
|---|---|
| 52 Week Change | -0.45 |
| Address1 | 45 Blue Sky Dr. |
| Address2 | Suite 101 |
| All Time High | 695.88 |
| All Time Low | 0.369 |
| Ask | 1.12 |
| Ask Size | 500 |
| Audit Risk | 9 |
| Average Daily Volume10 Day | 506,210 |
| Average Daily Volume3 Month | 794,898 |
| Average Volume | 794,898 |
| Average Volume10Days | 506,210 |
| Beta | 1.463 |
| Bid | 1.05 |
| Bid Size | 1,600 |
| Board Risk | 9 |
| Book Value | 0.233 |
| City | Burlington |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Compensation Risk | 7 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 1.1 |
| Current Ratio | 2.734 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,782,777,600 |
| Day High | 1.125 |
| Day Low | 1.08 |
| Debt To Equity | 210.649 |
| Display Name | Myomo |
| Dividend Date | 1,580,428,800 |
| Earnings Call Timestamp End | 1,778,185,800 |
| Earnings Call Timestamp Start | 1,778,185,800 |
| Earnings Timestamp | 1,778,184,000 |
| Earnings Timestamp End | 1,778,184,000 |
| Earnings Timestamp Start | 1,778,184,000 |
| Ebitda | -13,046,143 |
| Ebitda Margins | -0.31658 |
| Enterprise To Ebitda | -3.508 |
| Enterprise To Revenue | 1.111 |
| Enterprise Value | 45,768,036 |
| Eps Current Year | -0.31667 |
| Eps Forward | -0.25333 |
| Eps Trailing Twelve Months | -0.36 |
| Esg Populated | 0 |
| Exchange | ASE |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 1.07968 |
| Fifty Day Average Change | 0.020320058 |
| Fifty Day Average Change Percent | 0.018820446 |
| Fifty Two Week Change Percent | -45.0 |
| Fifty Two Week High | 2.22 |
| Fifty Two Week High Change | -1.12 |
| Fifty Two Week High Change Percent | -0.5045045 |
| Fifty Two Week Low | 0.605 |
| Fifty Two Week Low Change | 0.495 |
| Fifty Two Week Low Change Percent | 0.8181818 |
| Fifty Two Week Range | 0.605 - 2.22 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,497,274,200,000 |
| Float Shares | 26,868,160 |
| Forward Eps | -0.25333 |
| Forward P E | -4.3421626 |
| Free Cashflow | -10,472,450 |
| Full Exchange Name | NYSE American |
| Full Time Employees | 194 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Governance Epoch Date | 1,782,864,000 |
| Gross Margins | 0.65956 |
| Gross Profits | 27,180,300 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.090679996 |
| Held Percent Institutions | 0.40965 |
| Implied Shares Outstanding | 38,638,653 |
| Industry | Medical Devices |
| Industry Disp | Medical Devices |
| Industry Key | medical-devices |
| Is Earnings Date Estimate | 0 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Last Split Date | 1,580,428,800 |
| Last Split Factor | 1:30 |
| Long Business Summary | Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, Germany, and internationally. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living. It also provides MyoPro 2 that includes control technology, configuration software and user interface, and pop-out battery for extended use of the brace; MyoPro2+, which comprises 3D printed orthotics capability, software enhancements, and a design for donning and doffing of the device; MyoGames, a virtual training platform; and MyoPro 2x Video Library. In addition, the company offers MyoCare, a post-delivery program that provides follow-up care with clients, therapists, and referral sources; MYOMO; MyoPal; and MyoCoach. Its products are designed to help adults and adolescents with neuromuscular conditions due to brachial plexus injury, stroke, traumatic brain injury, spinal cord injury, and other neurological disorders. The company sells its products through various sales channels, including orthotics and prosthetics providers, veteran's administration, and distributors. Myomo, Inc. was incorporated in 2004 and is headquartered in Burlington, Massachusetts. |
| Long Name | Myomo, Inc. |
| Market | us_market |
| Market Cap | 42,502,520 |
| Market State | PRE |
| Max Age | 86,400 |
| Message Board Id | finmb_26981670 |
| Most Recent Quarter | 1,774,915,200 |
| Net Income To Common | -15,118,225 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 42,502,518 |
| Number Of Analyst Opinions | 5 |
| Open | 1.11 |
| Operating Cashflow | -14,031,891 |
| Operating Margins | -0.31217 |
| Overall Risk | 7 |
| Payout Ratio | 0.0 |
| Phone | 617 996 9058 |
| Pre Market Change | -0.024999976 |
| Pre Market Change Percent | -2.2421503 |
| Pre Market Price | 1.09 |
| Pre Market Time | 1,784,030,920 |
| Previous Close | 1.1 |
| Price Eps Current Year | -3.4736478 |
| Price Hint | 4 |
| Price To Book | 4.72103 |
| Price To Sales Trailing12 Months | 1.0313764 |
| Profit Margins | -0.36686 |
| Quick Ratio | 2.187 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | 0.0 |
| Regular Market Change Percent | 0.0 |
| Regular Market Day High | 1.125 |
| Regular Market Day Low | 1.08 |
| Regular Market Day Range | 1.08 - 1.125 |
| Regular Market Open | 1.11 |
| Regular Market Previous Close | 1.1 |
| Regular Market Price | 1.1 |
| Regular Market Time | 1,783,972,800 |
| Regular Market Volume | 261,552 |
| Return On Assets | -0.22608 |
| Return On Equity | -0.98526 |
| Revenue Growth | 0.029 |
| Revenue Per Share | 1.069 |
| Sand P52 Week Change | 0.20365608 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Share Holder Rights Risk | 6 |
| Shares Outstanding | 38,638,653 |
| Shares Percent Shares Out | 0.0631 |
| Shares Short | 2,439,681 |
| Shares Short Previous Month Date | 1,780,012,800 |
| Shares Short Prior Month | 3,444,046 |
| Short Name | Myomo Inc. |
| Short Percent Of Float | 0.0719 |
| Short Ratio | 1.63 |
| Source Interval | 15 |
| State | MA |
| Symbol | MYO |
| Target High Price | 10.0 |
| Target Low Price | 1.1 |
| Target Mean Price | 4.42 |
| Target Median Price | 3.0 |
| Total Cash | 15,696,404 |
| Total Cash Per Share | 0.406 |
| Total Debt | 18,961,924 |
| Total Revenue | 41,209,516 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -0.36 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 0.926995 |
| Two Hundred Day Average Change | 0.17300504 |
| Two Hundred Day Average Change Percent | 0.18662997 |
| Type Disp | Equity |
| Volume | 261,552 |
| Website | https://myomo.com |
| Zip | 1,803 |